Synthesis and Evaluation of Dibenzothiazepines: A Novel Class of Selective Cannabinoid-1 Receptor Inverse Agonists
作者:Hanna Pettersson、Anne Bülow、Fredrik Ek、Jacob Jensen、Lars K. Ottesen、Alma Fejzic、Jian-Nong Ma、Andria L. Del Tredici、Erika A. Currier、Luis R. Gardell、Ali Tabatabaei、Darren Craig、Krista McFarland、Thomas R. Ott、Fabrice Piu、Ethan S. Burstein、Roger Olsson
DOI:10.1021/jm801534c
日期:2009.4.9
relationships (SARs), new synthetic methodologies amenable for parallel synthesis were developed. The compounds were evaluated in a mammalian cell-based functional assay and in radioligand binding assays expressing recombinant human cannabinoid receptors (CB1 and CB2). In general, all of the compounds exhibited high binding selectivity at CB1 vs CB2 and the general SAR revealed a lead compound 11-(4-chlorophenyl)dibenzo[b
发现了一类新颖的CB1反向激动剂。为了有效地建立结构活性关系(SAR),开发了适用于平行合成的新合成方法。在基于哺乳动物细胞的功能测定和表达重组人大麻素受体(CB1和CB2)的放射性配体结合测定中对化合物进行了评估。通常,所有化合物在CB1和CB2上均表现出高结合选择性,并且一般SAR显示前导化合物11-(4-氯苯基)二苯并[ b,f ] [1,4]硫氮平-8-羧酸丁酰胺(12e)在与CB1受体活性相关的药效学模型中显示了出色的体内活性。低溶解度阻碍了12e的发展解决方案导致潜在的临床前候选药物11-(3-氯-4-氟苯基)二苯并[ b,f ] [1,4]硫氮平-8-羧酸丁酰胺(12h)。